Document Detail


Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications.
MedLine Citation:
PMID:  23187089     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: To assess whether fetal-derived hypermethylated RASSF1A concentrations in maternal plasma during pregnancy are altered in pregnancies associated with placental dysfunction manifested by intrauterine growth restriction (IUGR), preeclampsia (PE), or placental previa (PP) and whether this alteration can be detected in susceptible subjects before the onset of clinical disease. METHODS: We performed a real-time quantitative polymerase chain reaction to quantify RASSF1A concentrations before and after methylation-sensitive restriction digestion in maternal plasma at 7-41 gestational weeks of normal pregnancies (n = 161), IUGR (n = 43), PE (n = 22), PP (n = 14) and non-pregnant women (n = 20). RESULTS: A positive correlation was observed between fetal-derived hypermethylated RASSF1A concentration and gestational age for all study groups (r = 0.624, p < 0.001 for IUGR; r = 0.381, p = 0.042 for PE; r = 0.697, p < 0.001 for PP; r = 0.560, p < 0.001 for controls). The concentration of hypermethylated RASSF1A was relatively high at 7-14 gestational weeks in all patient groups. Hypermethylated RASSF1A concentration at 15-28 weeks was significantly higher in patients who subsequently developed IUGR (p = 0.002), PE (p < 0.001) or PP (p < 0.001) than in controls. CONCLUSION: We first demonstrated increased concentration of fetal-derived hypermethylated RASSF1A sequences according to advancing gestation and before the onset of the clinical manifestation of pregnancy complications secondary to placental dysfunction, such as IUGR, PE and PP. Hypermethylated RASSF1A in maternal plasma may be useful as a potential biomarker to detect placental-mediated pregnancy complications, regardless of fetal gender and polymorphism.
Authors:
M J Kim; S Y Kim; S Y Park; H K Ahn; J H Chung; H M Ryu
Related Documents :
552769 - The treatment with 2-brom-alfa ergocriptine in the syndrome amenorrhea-galactorrhea.
2138569 - Second-look laparoscopy after ectopic pregnancy.
2140989 - Reproductive outcome after laparoscopic salpingectomy for tubal pregnancy.
3469999 - Tubal resection and anastomosis. ii. isthmic salpingitis.
831489 - Single-application fertility-regulating device: description of a new instrument.
7959329 - Tubal anastomosis in the rat using the tissue adhesive cyanoacrylate (histoacryl).
24199979 - Effect of integrated yoga on anxiety, depression & well being in normal pregnancy.
8166199 - Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization...
6395269 - Pregnancy-associated depression of cell-mediated immunity.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-24
Journal Detail:
Title:  Placenta     Volume:  -     ISSN:  1532-3102     ISO Abbreviation:  Placenta     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006349     Medline TA:  Placenta     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Affiliation:
Laboratory of Medical Genetics, Cheil General Hospital and Women's Healthcare Center, Seoul, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Too few or too many? Reactions to removing versus retaining specific personality disorders in DSM-5.
Next Document:  Review: Modelling placental amino acid transfer--from transporters to placental function.